Quarterly Activity Chart
Adds vs. Reduces by Quarter
PaperPanda Equity Terminal
ORMP —
ORAMED PHARMACEUTICALS INC
CUSIP: 68403P203 · Held by 2 superinvestors · Combined value: $979,032
Latest News
Loading financials…
| # | Investor | % of Portfolio | Value ($) | Shares | Recent Activity | Share Change |
|---|---|---|---|---|---|---|
| 1 | Ken Griffin | 0.0% | $558,657 | 196,020 | ADD | +84,313 |
| 2 | Jim Simons | 0.0% | $420,375 | 147,500 | REDUCE | -1,400 |
| Investor | Activity | Share Change | % Change |
|---|---|---|---|
| Ken Griffin | ADD | +84,313 | +75.5% |
| Jim Simons | REDUCE | -1,400 | -0.9% |
| Investor | Activity | Share Change | % Change |
|---|---|---|---|
| Jim Simons | ADD | +4,700 | +3.3% |
| Ken Griffin | ADD | +1,591 | +1.4% |
Who Owns ORMP? Superinvestor Holdings
ORAMED PHARMACEUTICALS INC is held by 2 tracked superinvestors, with a combined position value of $979,032 . The largest positions are held by Ken Griffin (0.0% of portfolio), Jim Simons (0.0% of portfolio).
In the most recent quarter, 1 superinvestor added or initiated positions while 1 reduced or exited.